Business
Doseology Announces Option Grant
Doseology Announces Option
About this update from Doseology Sciences, Inc.
[{"type":"text","content":"(via TheNewswire)\n\n\n\n \n \n\nKelowna, BC – May 1, 2025 –TheNewswire -Doseology Sciences Inc.(CSE:MOOD|PINK:DOSEF|FSE:VU7) (“Doseology” or the “Company”), an innovator in precision-formulated performance solutions, announces it has granted 155,000 incentive stock options (“Options”) to Chris Jackson, the Company’s new CEO and member of the board of directors. The Options are exercisable at $0.40 per common share for a period of five years from the date of grant.About Doseology Sciences Inc.(CSE:MOOD|PINK:DOSEF|FSE:VU7)Doseology is a performance-driven innovation company at the intersection of biotechnology and advanced delivery systems, engineering precision-formulated oral stimulants that optimize energy, focus, and cognitive performance. Through science-backed research and cutting-edge formulation technologies, the Company is pioneering next-generation performance solutions that empower consumers to perform at their peak.On behalf of the Board of Directors,Chris Jackson\nCEO\nDoseology Sciences Inc.For more information, please contact the Company at:Email: [email protected]: www.doseology.com\nPhone:604.908.3095 \n\n\n\n \n\n\nForward Looking StatementsThis press release contains statements that constitute “forward‐looking information” within the meaning of applicable securities laws. Forward‐looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions. Readers are cautioned that forward‐looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or projections concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward‐looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance, or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward‐lo...